March 30, 2023 – Within five years of stopping the weight-loss drug Wegovy, most individuals regain all the burden they lost, and a few people may even gain more kilos, a senior official at drugmaker Novo Nordisk said at a conference on Wednesday.
In addition, it is probably going that inside two to a few years after stopping the injectable medications containing the lively ingredient semaglutide, you'll regain 50 percent of the kilos you lost, the official reported.
This recovery rate is barely slower than the speed that a Study 2022 A study funded by the corporate showed that semaglutide-based weight reduction resulted in regaining two-thirds of the lost weight inside a 12 months.
“I think that’s what we see when people go on diets or different exercise programs, similar to when they start a pharmacological treatment,” said Karin Conde-Knape, PhD, Senior Vice President of Global Drug Discovery at Novo Nordisk, during a CNBC Virtual Conference in regards to the way forward for healthcare. “As long as you keep your intake and your expenditure the same, you can control your weight. But if you deviate from that, you'll gain weight right back.”
Novo Nordisk produces two semaglutide injections: Wegovy and Ozempic. Ozempic is approved for the treatment of type 2 diabetes. Wegovy is approved for weight reduction and accommodates the next dose of semaglutide. Both have been shown to steer to significant weight reduction. The 2022 study showed that the common person lost 17% of their body weight while taking the drug for nearly 6 years.
Semaglutide mimics a hormone called glucagon-like peptide-1 (GLP-1), which helps the brain regulate appetite and food intake. It also can affect the sorts of foods someone craves. Conde-Knape told conference attendees that the drug doesn't alter an individual's neural networks, so weight reduction is probably not everlasting.